Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to targeting cancer and autoimmune ...

Edaravone may exert its neuroprotective effects in ALS by also correcting the abnormal localization of TDP-43, a key ...

At one point during her health journey, Chandler resident Erin Kienlen thought she had amyotrophic lateral sclerosis, or ALS.

announced clinical results from treating a patient with ALS (amyotrophic lateral sclerosis, also known as Lou Gehrig’s disease) with TRE-515 under the FDA Expanded Access program. TRE-515 ...

However, future randomized clinical trials with larger numbers of patients will be necessary to prove clinical benefit. About Amyotrophic Lateral Sclerosis Amyotrophic lateral sclerosis (ALS ...

However, future randomized clinical trials with larger numbers of patients will be necessary to prove clinical benefit. Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a ...

However, future randomized clinical trials with larger numbers of patients will be necessary to prove clinical benefit. Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease ...

However, future randomized clinical trials with larger numbers of patients will be necessary to prove clinical benefit. Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, is a ...

Statin use does not affect survival outcomes for ALS patients, so there may be no need to stop taking them after a diagnosis, ...